The fight against cancer has seen quite a few points of inflection and has traversed significant changes in the mindset. Once cancer was a near invincible adversary, and today cancer care is practiced with one inherent premise - cancer is conquerable! Our battle, at Apollo Gleneagles Hospitals, Kolkata, has seen several milestones too and we stand on the cusp of a very major one. Cancer care at Apollo completes two decades of excellence and expertise. In this transformative journey, spanning over two decades, Apollo has pioneered several game-changing developments and has set benchmarks in clinical and service excellence in cancer care. Cutting edge medical technology, stringent quality protocols and deep empathy have been the hallmarks of our cancer programme.
Our mission is to take the fight against cancer to the next frontier, and redefine clinical benchmarks and outcomes. Apollo Gleneagles Hospitals, Kolkata brings together the brightest minds in surgical, medical & radiation oncology, along with a complete range of high-end ancillary experts. For patients, we stand for hope and the resolute truth that cancer is conquerable ! Cancer care requires commitment, expertise and an indomitable spirit. It also demands innovation and a fresh way of thinking. At Apollo we believe we can help foster and nurture ideas that will trigger the next wave of brilliance in cancer care. Initatives like the International Cancer Conclave, back our vision with action, recharge our agenda with collaborative brilliance. Together I believe we have what is takes to fulfil our commitment, and make Cancer Conquerable. Here's to a brighter future. A healthier future.
Content goes here...
- Clinical excellence is rooted in the ever increasing depth and breadth of knowledge. Thus research and the sharing of that knowledge build up clinical excellence.
- The “National CME on Contemporary Developments in Oncology” was an endeavour of the Apollo Cancer Institute’s to share the knowledge on advancements in cancer management. This CME was hosted by AGCH on August, 2012 at Kolkata. It was addressed via video conferencing by Chairman of Apollo Group of Hospitals. Joint MD & Group MD of Apollo group also addressed the session. There were 14 presentations by 14 consultants from the ACIs spanning advancements in medical and surgical oncology, radiotherapy and BMT. An exhaustive discussion was conducted on clinical pathway-Modified Radical Mastectomy.
- Establishing a clinical pathway serves centres of excellence in a variety of ways like, streamlining the clinical procedure, establishing the procedure on evidence, improving the standard of care, streamlining the cost to the organization, and increasing the possibility of patient turnover. The ACIs have taken a step towards that direction by finalizing a consensus on the clinical pathway in modified radical mastectomy.
- Levels of care have been designated as assessment, diagnostics, consultations, medications, treatment/ interventions, nutrition, activity, education, discharge planning, and expected outcome.
- WHO review of literature states that in the years 1976 to 2007, 3125 patients were reported to be affected by radiotherapy incidents that led to adverse events. About 1% of the affected patients died due to radiation overdose toxicity. In this setting Apollo Gleneagles Hospitals, Kolkata have started the use of a tools which will monitor the adverse events with the aim of analyzing and minimizing /eliminating them. The Failure Mode Effect Analysis (FMEA) is thus being used in Radiotherapy in accordance to WHO World Alliance for Patient Safety.
- The BMT unit at AGCH has performed several BMT in the three years months with 100% survival.
- Allogeneic and Haploidentical BMT, both types are done in AGHL.
- We are now internationally acclaimed as a centre for Haploidentical BMT with international referrals.